AI assistant aims to simplify diabetes and obesity drug management
NCT ID NCT07546357
First seen Apr 25, 2026 · Last updated Apr 29, 2026 · Updated 1 time
Summary
This study is testing a new AI-powered tool called AIManage to help doctors and patients manage medications for diabetes and obesity. The tool will assist with adjusting doses and tracking side effects. The study involves 16 participants and is split into two phases: first, gathering feedback to improve the tool, then testing it in a randomized trial. The goal is to see if the AI tool makes medication management easier and more effective.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
NYU Langone Health
New York, New York, 10016, United States
Conditions
Explore the condition pages connected to this study.